Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Novartis
Novartis
OHSU Knight Cancer Institute
Hikma Pharmaceuticals LLC
Gruppo Italiano Malattie EMatologiche dell'Adulto
Pfizer
Hikma Pharmaceuticals LLC
Dana-Farber Cancer Institute
Novartis
Emory University
M.D. Anderson Cancer Center
Heidelberg University
National Institutes of Health Clinical Center (CC)
Novartis
M.D. Anderson Cancer Center
Il-Yang Pharm. Co., Ltd.
OHSU Knight Cancer Institute
Novartis
Teva Branded Pharmaceutical Products R&D, Inc.
Ariad Pharmaceuticals
M.D. Anderson Cancer Center
Children's Oncology Group
Novartis
Hospital Universitario Dr. Jose E. Gonzalez
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
Barbara Ann Karmanos Cancer Institute
Novartis
Novartis
Novartis
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Glasgow
Fred Hutchinson Cancer Center
Novartis
M.D. Anderson Cancer Center
National Cancer Institute (NCI)